Hazer Group (ASX:HZR) has completed its commercial demonstration plant and reactor test program, marking a step in the company's technological advancements. The achievement is expected to ...

Neumora Therapeutics (NASDAQ:NMRA), a clinical-stage biopharmaceutical company with a pipeline of seven brain disease programs, has released results from the Phase 3 KOASTAL-1 study evaluating ...

Eliza Labs, the developer behind ai16z (CRYPTO:AI16Z), has released a white paper detailing its vision for Web3-native artificial intelligence agents. The document outlines the capabilities of Eliza, ...

Recce Pharmaceuticals (ASX:RCE) has dosed all 30 patients in its Phase 2 clinical trial assessing the efficacy of RECCE 327 topical gel for the treatment of acute bacterial skin and skin structure ...

The Bank of England plans to launch the Digital Pound Lab in 2025 as part of its Central Bank Digital Currency (CBDC) design phase. Collaboration with HM Treasury and global experts focuses on privacy ...

Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical-stage biotechnology company, has announced positive results from its ongoing Phase 1b clinical study evaluating the use of its INTASYL® siRNA gene ...

Decentralised finance (DeFi) advocates believe artificial intelligence (AI) could be a game-changer in combating cybercrime and enhancing platform security. According to Peckshield’s Annual Crypto ...

Qantas Airways (ASX:QAN) has fallen behind its global counterparts in the latest on-time performance rankings, according to aviation analytics firm Cirium. The analysis revealed that only 73.8% of ...

In a strategic move reshaping its vaccine operations, WuXi Biologics announced on Monday that its subsidiary, WuXi Vaccines Ireland, has entered into an agreement with Merck & Co. (NYSE:MRK) to sell ...

British pharmaceutical giant GSK (NYSE:GSK) is reportedly in advanced talks to acquire IDRx, a privately-held biotechnology company focused on developing treatments for a rare type of tumor. According ...